DeepMed Research

ABIOMED, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1981-01-01

Employees: 2K

Market Cap: -

Website: http://www.abiomed.com

Clinical Trials

Breethe Abiomed Recovery regisTry (BART)

Suspended

Conditions: Heart Failure
Cardiopulmonary Bypass
ARDS

First Posted Date: 2022-07-25

Last Posted Date: 2024-06-24

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 1000

Registration Number: NCT05473130

Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol

Not Applicable

Conditions: High-Risk Percutaneous Coronary Intervention

Interventions: Device: Impella ECP

First Posted Date: 2022-04-19

Last Posted Date: 2025-01-27

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 556

Registration Number: NCT05334784

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Texas Health Presbyterian Hospital Dallas, Dallas, Texas, United States
🇺🇸
Adventist Health Glendale, Glendale, California, United States

and more 29 locations

Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

Not Applicable

Recruiting

Conditions: Heart Failure
Acute Decompensated Heart Failure

Interventions: Device: Impella BTR

First Posted Date: 2022-03-23

Last Posted Date: 2023-06-08

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 10

Registration Number: NCT05291884

Locations: 🇺🇸
Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸
Northwestern University, Evanston, Illinois, United States
🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

and more 4 locations

SURPASS Impella 5.5 Study

Completed

Conditions: Cardiogenic Shock
Acute Decompensated Heart Failure

Interventions: Device: Impella 5.5

First Posted Date: 2021-10-29

Last Posted Date: 2025-05-20

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 1017

Registration Number: NCT05100836

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

and more 12 locations

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Not Applicable

Recruiting

Conditions: Left Ventricular Dysfunction
Coronary Artery Disease

Interventions: Device: Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®
Device: IABP Intra-aortic balloon pump

First Posted Date: 2021-02-21

Last Posted Date: 2025-03-25

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 1252

Registration Number: NCT04763200

Locations: 🇺🇸
Northside Cardiovascular Institute, Lawrenceville, Georgia, United States
🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸
Abrazo Arizona Heart, Phoenix, Arizona, United States

and more 131 locations

Restore EF Observational Study

Completed

Conditions: NSTEMI - Non-ST Segment Elevation MI
Unstable Angina
Coronary Artery Disease
Angina, Stable

Interventions: Device: Prophylactic Impella support for a non-emergent PCI

First Posted Date: 2020-12-01

Last Posted Date: 2021-12-14

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 406

Registration Number: NCT04648306

Locations: 🇺🇸
St. Joseph's Medical Center, Phoenix, Arizona, United States
🇺🇸
Washington Regional Medical Center, Fayetteville, Arkansas, United States
🇺🇸
Northwest Medical Center, Springdale, Arkansas, United States

and more 18 locations

Impella ECP Early Feasibility Study

Not Applicable

Active, not recruiting

Conditions: High-risk Percutaneous Coronary Intervention

Interventions: Device: Impella ECP

First Posted Date: 2020-07-20

Last Posted Date: 2025-02-04

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 100

Registration Number: NCT04477603

Locations: 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States
🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States
🇺🇸
Henry Ford Health St. John Hospital, Detroit, Michigan, United States

and more 2 locations

The Smart Pump Study

Not Applicable

Active, not recruiting

Conditions: Cardiac Output

Interventions: Device: Impella CP with Smart Assist (Circulatory Support System)

First Posted Date: 2020-07-10

Last Posted Date: 2022-10-24

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 35

Registration Number: NCT04465201

Locations: 🇺🇸
Ochsner Clinical Foundation, New Orleans, Louisiana, United States
🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Ascension St. John Hospital, Detroit, Michigan, United States

and more 3 locations

The Global cVAD Study

Active, not recruiting

Conditions: Cardiovascular Diseases

Interventions: Device: ABIOMED, Inc. hemodynamic support devices

First Posted Date: 2019-10-23

Last Posted Date: 2021-05-10

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 20000

Registration Number: NCT04136392

Locations: 🇺🇸
University Cardiology Associates, Augusta, Georgia, United States
🇺🇸
St. Vincent Hospital, Worcester, Massachusetts, United States
🇺🇸
University of Southern California Keck Hospital, Los Angeles, California, United States

and more 48 locations

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

Not Applicable

Recruiting

Conditions: ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

Interventions: Device: Impella CP® placement prior to reperfusion with Primary PCI

First Posted Date: 2019-05-13

Last Posted Date: 2024-06-11

Lead Sponsor: Abiomed Inc.

Target Recruit Count: 668

Registration Number: NCT03947619

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸
The University of Arizona, Tucson, Arizona, United States

and more 61 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy